The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
暂无分享,去创建一个
A. Plückthun | C. Cambillau | A. Honegger | S. Spinelli | S. Jung | L. Pugliese | B. Schimmele | Sabine Jung
[1] A. Plückthun,et al. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries. , 2001, Journal of molecular biology.
[2] A. Plückthun,et al. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. , 2001, Journal of molecular biology.
[3] A. Plückthun,et al. The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains. , 2001, Journal of molecular biology.
[4] A. Plückthun,et al. Stability engineering of antibody single-chain Fv fragments. , 2001, Journal of molecular biology.
[5] A. Plückthun,et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. , 2000, Journal of molecular biology.
[6] A. Plückthun,et al. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. , 1999, Cancer research.
[7] A. Plückthun,et al. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering. , 1999, Biochemistry.
[8] C T Verrips,et al. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. , 1999, Biochimica et biophysica acta.
[9] J. Arends,et al. Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding. , 1998, Protein engineering.
[10] A. Plückthun,et al. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge. , 1998, Journal of molecular biology.
[11] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[12] A. Plückthun,et al. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. , 1998, Biochemistry.
[13] A. Plückthun,et al. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly , 1998, FEBS letters.
[14] R L Brady,et al. VL:VH domain rotations in engineered antibodies: Crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs , 1997, Proteins.
[15] A. Plückthun,et al. Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting. , 1997, Protein engineering.
[16] H. Bedouelle,et al. Recognition of E. coli tryptophan synthase by single‐chain Fv fragments: comparison of PCR‐cloning variants with the parental antibodies , 1997, Journal of molecular recognition : JMR.
[17] M. Little,et al. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity. , 1997, Protein engineering.
[18] A. Plückthun,et al. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. , 1997, Journal of immunological methods.
[19] Q. Gu,et al. Multicopy suppressors of prc mutant Escherichia coli include two HtrA (DegP) protease homologs (HhoAB), DksA, and a truncated R1pA , 1996, Journal of bacteriology.
[20] N. Ban,et al. Structure of an anti‐idiotypic Fab against feline peritonitis virus‐neutralizing antibody and a comparison with the complexed Fab , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] R. Williams,et al. Crystal structure of a diabody, a bivalent antibody fragment. , 1994, Structure.
[22] S. Muyldermans,et al. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. , 1994, Protein engineering.
[23] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[24] J. Navaza,et al. AMoRe: an automated package for molecular replacement , 1994 .
[25] S. Muyldermans,et al. Naturally occurring antibodies devoid of light chains , 1993, Nature.
[26] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[27] R. Poljak,et al. Structural patterns at residue positions 9, 18, 67 and 82 in the VH framework regions of human and murine immunoglobulins. , 1993, Journal of molecular biology.
[28] L. Presta,et al. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. , 1993, Journal of molecular biology.
[29] A. Edmundson,et al. Three-dimensional structure of an Fv from a human IgM immunoglobulin. , 1992, Journal of molecular biology.
[30] G. Nemerow,et al. Strategies in the crystallization of glycoproteins and protein complexes , 1992 .
[31] Sung-Hou Kim,et al. Sparse matrix sampling: a screening method for crystallization of proteins , 1991 .
[32] R. Poljak,et al. Three-dimensional structure of an idiotope–anti-idiotope complex , 1990, Nature.
[33] P. V. von Hippel,et al. Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.
[34] M. J. Adams. Preparation and Analysis of Protein Crystals , 1983 .
[35] E. Kabat,et al. ATTEMPTS TO LOCATE COMPLEMENTARITY‐DETERMINING RESIDUES IN THE VARIABLE POSITIONS OF LIGHT AND HEAVY CHAINS * , 1971, Annals of the New York Academy of Sciences.
[36] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[37] A. Plückthun,et al. Construction of scFv Fragments from Hybridoma or Spleen Cells by PCR Assembly , 2001 .
[38] B. Rupp,et al. Structure of a monoclonal 2E8 Fab antibody fragment specific for the low-density lipoprotein-receptor binding region of apolipoprotein E refined at 1.9 A. , 1999, Acta crystallographica. Section D, Biological crystallography.
[39] A. Plu,et al. An intrinsically stable antibody scFv fragment can tolerate the loss of both disul¢de bonds and fold correctly , 1998 .
[40] A. Edmundson,et al. Three-dimensional structure of a human Fab with high affinity for tetanus toxoid. , 1998, Immunotechnology : an international journal of immunological engineering.
[41] S. Parkin,et al. Structure of a monoclonal 2 E 8 Fab antibody fragment speci ® c for the low-density lipoprotein-receptor binding region of apolipoprotein E re ® ned at 1 . 9 AÊ , 1998 .
[42] C. Pace. Measuring and increasing protein stability. , 1990, Trends in biotechnology.
[43] Pace Cn,et al. Measuring and increasing protein stability , 1990 .
[44] C. Yanisch-Perron,et al. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.